23 results on '"Michetti, G"'
Search Results
2. 750 MHZ ZERO-POWER MEMS-BASED WAKE-UP RECEIVER WITH -60 DBM SENSITIVITY
3. A Single-Center 10-Year Experience with Pasireotide in Cushing’s Disease: Patients’ Characteristics and Outcome
4. Effectiveness of direct egfr mutations research at time of diagnostic biopsy for lung cancer: a single institution outcome research
5. The role of an acute pasireotide suppression test in predicting response to treatment in patients with Cushing’s disease: findings from a pilot study
6. Second-line chemotherapy in malignant pleural mesothelioma: Results of a retrospective multicenter survey
7. A retrospective analysis of second-line chemotherapy for malignant pleural mesothelioma (MPM).
8. 9085 A platinum based second line rechallenge chemotherapy improves survival in small cell lung cancer patients
9. 9129 Outcomes of malignant pleural mesothelioma patients treated with second-line chemotherapy (SL): a retrospective analysis of 161 patients
10. Outcomes of small cell lung cancer (SCLC) patients treated with second-line chemotherapy (SL): A retrospective analysis of 166 patients
11. 148PD OUTCOMES OF SMALL CELL LUNG CANCER (SCLC) PATIENTS TREATED WITH SECOND-LINE CHEMOTHERAPY (SL): A RETROSPECTIVE ANALYSIS OF 166 PATIENTS
12. Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone
13. What is the real benefit of adjuvant chemotherapy in the Adjuvant Navelbine International Trialist Association trial?
14. O-096 Phase III study in patients with stage IV non small-cell lungcancer (NSCLC) treated with two cycles of cisplatin/gemcitabine followed by a randomization to three additional cycles of the same combination or gemcitabine alone
15. P-414 18F-FDG-PET in mesothelioma: Is there a prognostic value?
16. Phase III study in stage IV non-small-cell lung cancer (NSCLC) patients (pts) treated with two cycles of cisplatin/gemcitabine followed by a randomization to three additional cycles of the same combination or gemcitabine alone
17. Early data of phase III study in patients (pts) with stage IV non-small-cell lung cancer (NSCLC) treated with two cycles of cisplatin/gemcitabine followed by a randomization to three additional cycles of the same combination or gemcitabine alone
18. Early data of phase III study in patients (pts) with stage IV non-small-cell lung cancer (NSCLC) treated with two cycles of cisplatin/gemcitabine followed by a randomization to three additional cycles of the same combination or gemcitabine alone
19. Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer
20. Preoperative treatment with paclitaxel and carboplatin in locally advanced non small cell lung cancer (NSCLC): A phase II trial
21. Cefepime Versus Ceftazidime in the Treatment of Lower Respiratory Tract Infections
22. Bronchoalveolar lavage and its role in diagnosing cobalt lung disease
23. Uncommon evolution of fibrosing alveolitis in a hard metal grinder exposed to cobalt dusts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.